Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1
Clinical trial NCT02687230 · TERMINATED
Trial details
- NCT number
- NCT02687230
- Sponsor
- BioNTech Research & Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-11
- Primary completion
- 2017-05-05
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.